Yixintang Pharmaceutical Hits Day Low Amid Price Pressure, Drops to CNY 11.95

Yixintang Pharmaceutical Group Co., Ltd. experienced a notable decline today, with the stock dropping by 5.82% and reaching an intraday low of CNY 11.95. This performance is part of a broader trend, as the company has faced consistent challenges, reflected in its one-week performance of -9.17% and a one-month decline of -11.52%. Over the past year, Yixintang has underperformed significantly, with a return of -7.56%, contrasting sharply with the China Shanghai Composite's gain of 13.33%. The company's financial metrics indicate ongoing difficulties, including a net sales figure of CNY 4,086.54 million and an operating cash flow that has reached its lowest point at CNY 1,924.6 million. Despite a high dividend yield of 5.50%, the company's return on equity stands at a modest 1.50%, and it has reported negative results for the last seven consecutive quarters. With a market capitalization of CNY 5,417 million, Yixintang continues to face significant headwinds in the retailing industry.